Drug price history · CMS NADAC read 11 November 2026
Generic
$0.247 per mL at the 2013 year-end survey (4 NDCs) and $1.19 at the 2026 survey (8 NDCs): +383%.
| Year-end survey | Median per mL | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.247 | $0.212 to $0.511 | 4 |
| 2014 (2014-12-31) | $0.908 | $0.903 to $1.18 | 4 |
| 2015 (2015-12-30) | $1.87 | $1.72 to $3.18 | 4 |
| 2016 (2016-12-28) | $1.72 | $1.72 to $3.28 | 3 |
| 2017 (2017-12-27) | $2.26 | $1.51 to $3.00 | 2 |
| 2018 (2018-12-26) | $2.31 | $1.39 to $3.22 | 2 |
| 2019 (2019-12-25) | $1.44 | $1.44 to $3.90 | 5 |
| 2020 (2020-12-30) | $1.30 | $1.30 to $3.43 | 5 |
| 2021 (2021-12-29) | $1.07 | $1.07 to $2.70 | 5 |
| 2022 (2022-12-28) | $0.971 | $0.971 to $2.66 | 5 |
| 2023 (2023-12-27) | $0.943 | $0.943 to $2.99 | 5 |
| 2024 (2024-12-25) | $2.64 | $0.660 to $2.64 | 7 |
| 2025 (2025-12-31) | $1.42 | $0.516 to $2.33 | 8 |
| 2026 (2026-11-11) | $1.19 | $0.419 to $2.74 | 8 |
Generic
$0.458 per unit at the 2013 year-end survey (6 NDCs) and $0.304 at the 2026 survey (4 NDCs): −34%.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.458 | 6 | |
| 2014 (2014-12-31) | $0.500 | 6 | |
| 2015 (2015-12-30) | $0.539 | 6 | |
| 2016 (2016-12-28) | $0.561 | 6 | |
| 2017 (2017-12-27) | $0.415 | 6 | |
| 2018 (2018-12-26) | $0.395 | 6 | |
| 2019 (2019-12-25) | $0.427 | 6 | |
| 2020 (2020-12-30) | $0.402 | 6 | |
| 2021 (2021-12-29) | $0.366 | 6 | |
| 2022 (2022-12-28) | $0.383 | 6 | |
| 2023 (2023-12-27) | $0.417 | 6 | |
| 2024 (2024-12-25) | $0.352 | 6 | |
| 2025 (2025-12-31) | $0.314 | 5 | |
| 2026 (2026-11-11) | $0.304 | 4 |
Generic
$0.168 per gram at the 2019 year-end survey (17 NDCs) and $0.133 at the 2026 survey (14 NDCs): −21%.
| Year-end survey | Median per gram | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2019 (2019-12-25) | $0.168 | $0.065 to $0.379 | 17 |
| 2020 (2020-12-30) | $0.097 | $0.060 to $0.328 | 14 |
| 2021 (2021-12-29) | $0.144 | $0.068 to $0.265 | 12 |
| 2022 (2022-12-28) | $0.152 | $0.048 to $0.276 | 12 |
| 2023 (2023-12-27) | $0.161 | $0.047 to $0.277 | 12 |
| 2024 (2024-12-25) | $0.150 | $0.049 to $0.242 | 13 |
| 2025 (2025-12-31) | $0.134 | $0.050 to $0.207 | 15 |
| 2026 (2026-11-11) | $0.133 | $0.047 to $0.343 | 14 |
Generic Over the counter
$0.082 per gram at the 2019 year-end survey (3 NDCs) and $0.090 at the 2026 survey (4 NDCs): +10%.
| Year-end survey | Median per gram | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2019 (2019-12-25) | $0.082 | 3 | |
| 2020 (2020-12-30) | $0.085 | 3 | |
| 2021 (2021-12-29) | $0.082 | 4 | |
| 2022 (2022-12-28) | $0.085 | 3 | |
| 2023 (2023-12-27) | $0.090 | 3 | |
| 2024 (2024-12-25) | $0.088 | 3 | |
| 2025 (2025-12-31) | $0.087 | 3 | |
| 2026 (2026-11-11) | $0.090 | 4 |
Generic
$0.545 per gram at the 2013 year-end survey (18 NDCs) and $0.173 at the 2018 survey (20 NDCs): −68%.
| Year-end survey | Median per gram | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.545 | $0.065 to $0.792 | 18 |
| 2014 (2014-12-31) | $0.508 | $0.062 to $0.783 | 18 |
| 2015 (2015-12-30) | $0.507 | $0.066 to $0.693 | 18 |
| 2016 (2016-12-28) | $0.425 | $0.063 to $0.614 | 19 |
| 2017 (2017-12-27) | $0.223 | $0.070 to $0.465 | 20 |
| 2018 (2018-12-26) | $0.173 | $0.067 to $0.404 | 20 |
Generic
$0.352 per unit at the 2024 year-end survey (2 NDCs) and $0.304 at the 2026 survey (2 NDCs): −14%, a thin comparison.
| Year-end survey | Median per unit | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2024 (2024-12-25) | $0.352 | 2 | |
| 2025 (2025-12-31) | $0.314 | 2 | |
| 2026 (2026-11-11) | $0.304 | 2 |
Generic Over the counter
$0.287 per gram at the 2013 year-end survey (2 NDCs) and $0.308 at the 2015 survey (1 NDC): +7%, a thin comparison.
| Year-end survey | Median per gram | Lowest to highest | NDCs priced |
|---|---|---|---|
| 2013 (2013-12-25) | $0.287 | $0.276 to $0.298 | 2 |
| 2014 (2014-12-31) | $0.312 | $0.289 to $0.335 | 2 |
| 2015 (2015-12-30) | $0.308 | 1 |
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
The FDA Orange Book lists 5 generic makers as marketed in its largest dosage form for Clotrimazole, and the first generic approval is dated 16 July 1993. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.
Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Clotrimazole on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).